Lilly Zyprexa Efficacy In Bipolar Mixed Mania May Be Highlighted By Firm
This article was originally published in Pharmaceutical Approvals Monthly
Zyprexa (olanzapine) effectiveness in bipolar disorder (BPD) patients with mixed mania and rapid cycling could be one of the features that Lilly highlights in promoting the new indication for its antipsychotic drug.
You may also be interested in...
Redeeming a priority review voucher obtained by developing a drug for a tropical disease will cost companies $6.1 million in fiscal 2011
The paradoxical finding that Dendreon's cancer immunotherapeutic Provenge (sipuleucel-T) improved overall survival in men with metastatic castration-resistant prostate cancer but did not appear to slow the progression of the disease is raising questions about the future of clinical development for the burgeoning class